Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · IEX Real-Time Price · USD
2.790
+0.010 (0.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Harvard Bioscience Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Harvard Bioscience.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for HBIO.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 2 | 2 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +150.90% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +150.90% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +150.90% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +43.37% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +79.21% | Nov 9, 2022 |
Financial Forecast
Revenue This Year
114.19M
from 112.25M
Increased by 1.73%
Revenue Next Year
126.53M
from 114.19M
Increased by 10.81%
EPS This Year
0.20
from -0.08
EPS Next Year
0.29
from 0.20
Increased by 46.15%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 118.6M | 131.4M | 144.9M |
| Avg | 114.2M | 126.5M | 140.8M |
| Low | 108.8M | 120.5M | 135.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.6% | 15.0% | 14.5% |
| Avg | 1.7% | 10.8% | 11.2% |
| Low | -3.1% | 5.6% | 6.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.22 | 0.32 | 0.37 |
| Avg | 0.20 | 0.29 | 0.36 |
| Low | 0.18 | 0.26 | 0.34 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 58.4% | 26.4% |
| Avg | - | 46.2% | 22.8% |
| Low | - | 33.0% | 18.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.